skip to Main Content
MRIGLOBAL SUPPORTS PRE-CLINICAL DRUG DEVELOPMENT AND MANUFACTURE FOR NATIONAL INSTITUTES OF HEALTH NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES (NCATS)

MRIGLOBAL SUPPORTS PRE-CLINICAL DRUG DEVELOPMENT AND MANUFACTURE FOR NATIONAL INSTITUTES OF HEALTH NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES (NCATS)

MRIGlobal is supporting pre-clinical drug development for the National Institutes of Health (NIH) National Center…

KEEP READING
HIGH CONTAINMENT FACILITY DEVELOPMENT

HIGH CONTAINMENT FACILITY DEVELOPMENT

Large, complex integration programs are our forte. Our CBRNE and containment expertise spans decades and…

KEEP READING
TESTING AND EVALUATION: CUTTING-EDGE TOOLS OF THE TRADE

TESTING AND EVALUATION: CUTTING-EDGE TOOLS OF THE TRADE

The same technologies originally developed for monitoring chemical threat agents can be used to monitor…

KEEP READING

MRIGLOBAL SUPPORTS PRE-CLINICAL DRUG DEVELOPMENT AND MANUFACTURE FOR NATIONAL INSTITUTES OF HEALTH NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES (NCATS)

Within NCATS, MRIGlobal Awarded “CRO Support for NCATS Drug Substance and Development” Kansas City, Mo.…

KEEP READING

MRIGLOBAL PROVIDES BROAD RANGE OF SUPPORT TO THE U.S. DEPARTMENT OF DEFENSE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL AND BIOLOGICAL DEFENSE (JPEO-CBD)

A key task under the Homeland Defense Technical Area Tasks contract awarded to MRIGlobal will…

KEEP READING

MRIGLOBAL SUPPORTS BARDA WITH DEVELOPMENT OF MEDICAL COUNTERMEASURES FOR BIOLOGICAL THREATS

Biomedical Advanced Research and Development Authority (BARDA) Continues Relationship with MRIGlobal in Nonclincial Studies Network…

KEEP READING

MRIGLOBAL WINS $13.7M NIH/NIAID QUALITY ASSESSMENT CONTRACT FOR MYCOBACTERIUM TUBERCULOSIS

MRIGlobal will evaluate technologies and specimen processes to support the National Institute of Allergy and…

KEEP READING

MRIGLOBAL WINS $13.7M NIH/NIAID QUALITY ASSESSMENT CONTRACT FOR MYCOBACTERIUM TUBERCULOSIS

MRIGlobal will evaluate technologies and specimen processes to support the National Institute of Allergy and…

KEEP READING

MRIGLOBAL’S DESIGN OF NEXT GENERATION MEDEVAC BIOCONTAINMENT SYSTEM WINS R&D MAGAZINE

MRIGlobal’s Containerized Bio Containment System (CBCS) wins R&D Magazine’s R&D 100 Award   Kansas City,…

KEEP READING

MRIGLOBAL, THERMO FISHER SCIENTIFIC, ARIZONA STATE UNIVERSITY LEAD TESTING OF DIAGNOSTIC MEDICAL COUNTERMEASURES PROGRAM FOR U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES’ OFFICE OF THE ASSISTANT SECRETARY FOR PREPAREDNESS RESPONSE (ASPR)

ASPR’s Biomedical Advanced Research and Development Authority (BARDA) will provide up to $100M over 10…

KEEP READING

MRIGLOBAL FURTHERS STUDY OF ZIKA VIRUS INFECTION RESULTING IN MICROCEPHALY USING 2016 PATTON TRUST RESEARCH DEVELOPMENT GRANT

$50K Grant was awarded by The Kansas City Area Life Sciences Institute Kansas City, Mo.…

KEEP READING

MRIGLOBAL LEADS INTERNATIONAL RESEARCH COLLABORATION FOR TULAREMIA VACCINE

Collaboration includes scientists from Canada, Sweden, U.S.  in $6.2 million Defense Threat Reduction Agency contract…

KEEP READING

WORLD’s LEADING, NEXT-GENERATION MEDEVAC BIOCONTAINMENT UNITS REVEALED

Partnership between U.S. State Department, and the Paul G. Allen Ebola Program, developed by MRIGlobal…

KEEP READING

MRIGLOBAL LEADS STUDY AND PILOT PROJECT FOR REX INVESTMENT LIMITED TO ELECTRIFY RURAL TANZANIA

Funded by $818K (USD) Grant from US Trade and Development Agency, Project will use PV-Battery-Diesel…

KEEP READING

MRIGLOBAL DEVELOPS WHOLE GENOME SEQUENCING DIAGNOSTIC SYSTEM

Sample-to-Sequence System has Potential to Revolutionize Clinical Diagnostics. Faster Diagnoses Result in Better Health Outcomes.…

KEEP READING

MRIGLOBAL WINS $54 MILLION NIH NEUROLOGICAL DISORDERS AND STROKE CONTRACT TO SUPPORT DRUG DEVELOPMENT

National Institutes of Health Neurological Disorders and Stroke Contract Will Support Drug Manufacturing and ormulation…

KEEP READING